 CARLSBAD, Calif.--BUSINESS WIRE--- LCTX CIRM--Lineage Cell Therapeutics, Inc. NYSE American and TASE: LCTX, a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has entered into an exclusive option and license agreement with Neurgain Technologies, Inc. Neurgain, a medical device company that is commercializing technology developed by neurosurgeons at the University of California San Diego UC San Diego. Under the terms of the 